Enzalutamide, a second generation androgen receptor antagonist: development and clinical applications in prostate cancer. [electronic resource]
- Current oncology reports Apr 2013
- 69-75 p. digital
Publication Type: Journal Article
1534-6269
10.1007/s11912-013-0293-9 doi
Androgen Receptor Antagonists--therapeutic use Antineoplastic Agents--therapeutic use Benzamides Clinical Trials as Topic Drug Approval Humans Male Nitriles Phenylthiohydantoin--analogs & derivatives Prostatic Neoplasms--drug therapy Survival Analysis